Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 10/20 | 0.54 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | SCN1A | P35498 | 1/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.47 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7407665 | 0.97 | HRH3 (0.51) | PTGER4PTGER2HRH3MAOBKDM4E | |
| SCHEMBL7412956 | 0.92 | HRH3 (0.49) | HRH3MAOBKDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL7406231 | 0.92 | PTGER4 (0.56) | PTGER4PTGER2HRH3MAOBKDM4E | |
| SCHEMBL8669709 | 0.83 | DRD2 (0.56) | HRH3KDM4E | |
| SCHEMBL5172227 | 0.83 | KDM4E (0.64) | KDM4E | |
| SCHEMBL1583103 | 0.78 | KDM4E (0.69) | HRH3MAOBKDM4E | |
| Hydrochloric Acid SCHEMBL28203039 | 0.77 | KCNK3 (0.51) | PTGER4SMN1; SMN2 | |
| SCHEMBL15400625 | 0.77 | PTGER4 (0.64) | PTGER4PTGER2KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL15400624 | 0.77 | PTGER4 (0.64) | PTGER4PTGER2KDM4EALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8667301 | 0.77 | SLC6A4 (0.47) | PTGER4SMN1; SMN2SCN1ASCN2ASCN3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5198449-A | N-substituted alpha-arylazacycloalkylmethanamines and their use as cardiovascular agents | A. H. ROBINS COMPANY INCORPORATED (US) | 1993-03-30 | — | — | US | disclosed |